Khosrovi Behzad 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 12, 2012
Insider Transaction Report
Form 4
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2012-10-10+25,000→ 511,283 totalExercise: $1.29From: 2013-10-10Exp: 2022-10-10→ Common Stock (25,000 underlying)